When and how should osteoporosis be treated?
Välimäki, M.
Duodecim; Laaketieteellinen Aikakauskirja 109(20): 1785-1792
1993
ISSN/ISBN: 0012-7183 PMID: 7737001 Document Number: 411632
Document emailed within 1 workday
Related Documents
Orozco, P.; Zwart, M. 2003: How can corticosteroid-induced osteoporosis be prevented and treated? Medicina Clinica 121(16): 639Límanová, Z.; Stĕpán, J. 1992: The risk for osteoporosis in persons treated with thyroid hormones Vnitrni Lekarstvi 38(9): 860-867
Pumarino, H. 1990: Osteoporosis in a man with idiopathic hypercalciuria, renal variety, treated with a hypocalcic diet Revista Medica de Chile 118(4): 437-440
Palma, L.F. 1982: Family Practice Grand Rounds. Postmenopausal osteoporosis and estrogen therapy: who should be treated? Journal of Family Practice 14(2): 355-359
Izaks, G.J.; Westendorp, R.G.J. 2003: Osteoporosis in elderly women should always be treated, despite the new professional guideline from the Dutch Institute for Health Care Improvement (CBO) Nederlands Tijdschrift Voor Geneeskunde 147(13): 588-590
Yang, K.; Cai, S.-C.; Zhu, C.-F.; Fei, A.-H.; Qin, X.-F.; Xia, J.-G. 2014: Clinical study on primary osteoporosis treated with spreading moxibustion for warming yang and activating blood circulation Zhongguo Zhen Jiu 34(6): 555-558
Benucci, M.; Dolenti, S.; Saviola, G.; Manfredi, M. 2006: Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate Recenti Progressi in Medicina 97(1): 24-27
Arvay, G.; Zsemlye, L.; Kiss-Antal, M. 1979: Blood fluoride levels and urinary fluoride excretion in osteoporosis treated with fluorides Orvosi Hetilap 120(9): 513-515
Pongchaiyakul, C.; Wanothayaroj, E. 2007: Performance of the Khon Kaen Osteoporosis Study (KKOS) score for identifying osteoporosis in men Journal of the Medical Association of Thailand 90(8): 1518-1523
Robin, J.C.; Ambrus, J.L. 1982: Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis Research Communications in Chemical Pathology and Pharmacology 35(3): 491-498
Zhang, X.; Lin, J.; Yang, X.; Fei, Q.; Wang, B.; Yang, Y.; Li, J.; Ma, Z.; Zhao, F.; Wang, Q. 2015: Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderly male Zhonghua Yi Xue Za Zhi 95(41): 3366-3369
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Joseph, P.; Hughes, D. 1997: Osteoporosis. Guidelines for general practitioners. Osteoporosis Australia Australian Family Physician 26(10): 1181-5 1188-91 1194-6
Spencer, H.; Kramer, L. 1986: NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis Journal of Nutrition 116(2): 316-319
Syc, S. 1971: Causes of cortisol-induced osteoporosis and Cushing's disease osteoporosis Wiadomosci Lekarskie 24(1): 41-43
Chang, S.Fang.; Yang, R.Sen. 2014: Determining the cut-off point of osteoporosis based on the osteoporosis self-assessment tool, body mass index and weight in Taiwanese young adult women Journal of clinical nursing 23(17-18): 2628-2635
Cunha-Borges, J.L.; Mier, G.Meléndez.; Casas, Ní.; Medina, A.; Molina, J.Fernando.; García, M.Laura.; Oliveria, L.Guimarães.; Caselato, M.S.; Cruz, Aélica.C.; Ippolito, V.; Flórez, S. 2019: Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS) Advances in Rheumatology 59(1): 46
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584